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Background: Sperm chromatin structure is often impaired; mainly due to oxidative damage. Antioxidant
treatments do not consistently produce fertility improvements and, when given at high doses, they might block
essential oxidative processes such as chromatin compaction. This study was intended to assess the effect on male
sub-fertility of a pure one carbon cycle nutritional support without strong antioxidants.
Methods: Male partners of couples resistant to at least 2 assisted reproductive technology (ART) attempts, with no
evidence of organic causes of infertility and with either DNA fragmentation index (DFI) measured by Terminal
deoxynucleotidyl transferase dUTP Nick End Labeling (TUNEL) or nuclear decondensation index (SDI) measured by
aniline blue staining exceeding 20%, were invited to take part in a trial of a nutritional support in preparation
for a further ART attempt. The treatment consisted of a combination of B vitamins, zinc, a proprietary opuntia
fig extract and small amounts of N-acetyl-cysteine and Vitamin E (Condensyl™), all effectors of the one
carbon cycle.
Results: 84 patients were enrolled, they took 1 or 2 Condensyl™ tablets per day for 2 to 12 months. Positive
response rates were 64.3% for SDI, 71.4% for DFI and 47.6% for both SDI and DFI. Eighteen couples (21%)
experienced a spontaneous pregnancy before the planned ART cycle, all ended with a live birth. The remaining 66
couples underwent a new ART attempt (4 IUI; 18 IVF; 44 ICSI) resulting in 22 further clinical pregnancies and 15 live
births. The clinical pregnancy rate (CPR) and the live birth rate (LBR) were 47.6% and 39.3% respectively. The full
responders, i.e. the 40 patients achieving an improvement of both SDI and DFI, reported a CPR of 70% and a LBR of
57.5% (p < 0.001).
Conclusions: Nutritional support of the one carbon cycle without strong antioxidants improves both the SDI and
the DFI in ART resistant male partners and results in high pregnancy rates suggesting a positive effect on their
fertility potential.
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The role of the male factor in couples’ infertility is diffi-
cult to quantify as it can be masked by the variable fer-
tility of the female partner. However, according to the
latest guidelines of the European Association of Urology
[1], a male-infertility-associated factor is found together
with abnormal semen parameters in 50% of involuntarily* Correspondence: maurizio.dattilo@parthenogen.ch
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unless otherwise stated.childless couples; in 30-40% of cases no male-infertility-
associated factor is found (idiopathic male infertility).
A retrospective and descriptive study of 35 year old
men using data registered by Fivnat (France) reported a
decrease of the average sperm concentration from 73.6
million/ml in 1989 to 49.9 million/ml in 2005 [2],
strongly suggesting that the changing environment sig-
nificantly affect male fertility. Availability of diagnostic
aids to assess oxidative damage, particularly sperm DNA
fragmentation Index (DFI) and Sperm chromatin Decon-
densation Index (SDI), has given rise to great interest inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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a variety of interventions aimed at the correction of the
oxidative imbalance. In the past decade about 20 pub-
lished clinical trials confirmed that oral antioxidants
exert a positive effect on sperm oxidative stress; how-
ever, the majority of these studies were small, heteroge-
neous and did not generate sufficient data to confirm
whether these improvements result in improved second-
ary outcomes [3]. Nevertheless, the latest available
Cochrane review [4] concluded that antioxidant supple-
mentation in sub-fertile males may improve the out-
comes of live birth and pregnancy rate for sub-fertile
couples undergoing Assisted Reproductive Technologies
(ART): based on 20 live births from a total of 214 cou-
ples in three studies.
On the other hand, two recent clinical reviews [3,5] con-
cerning antioxidant treatments for male infertility warned
of the risks of depleting essential physiological reactive
oxygen species (ROS), potentially leading to “reductive
stress” [3] which can negatively affect capacitation and the
acrosome reaction [5] when high doses of powerful anti-
oxidant combinations are used. These substances have the
potential to interfere with the essential process of sperm
chromatin compaction that is largely based on the forma-
tion of disulfide bridges between the -SH groups of the
cysteine-enriched protamines [6]. This is a mild oxidative
reaction that could be impaired by “reductive stress”, as
shown for Vitamin C in vitro [7]. Treatment with
powerful antioxidants, although improving some measuresFigure 1 The one carbon cycle and the transsulphuration pathway. Th
transmethylation reactions: methionine is the carbon unit donor, being act
acceptor generates S-adenosyl-homocysteine and then Hcy. Hcy is subsequ
enter the transsulphuration pathway (lower part) by forming a complex wi
to the synthesis of GSH.of oxidative damage, e.g. DFI, may result in the worsening
of the SDI – a situation that has been observed in a clin-
ical setting [8]. An alternative approach, based upon the
body’s own homeostatic system, that minimises the un-
wanted actions whilst maximizing the desired actions
should be considered.
An oxidative attack could be neutralized by the en-
dogenous metabolism, where the universal reducing
agent is reduced glutathione (GSH). GSH synthesis is
largely based on the transsulphuration of homocysteine
(Hcy) formed within the so-called one carbon cycle - a
ubiquitous biochemical pathway.
When a molecule is to be elongated by the addition of
a methyl unit a molecule of homocysteine is formed in
almost all instances, leading to a huge build up of it
(Figure 1). Homocysteine subsequently undergoes either
a remethylation to methionine and activation to S-
adenosyl-methionine (SAMe) or transulphuration to
GSH “on-demand”. The rate of Hcy transulfuration to
GSH is redox-regulated as the key enzyme, cystathionine-
beta-synthase (CBS), contains a heme cofactor that func-
tions as a redox sensor: once an oxidative imbalance
occurs the heme is oxidized from the ferrous (Fe++) to fer-
ric (Fe+++) state which activates the enzyme [9]. The
greater the oxidative load, the greater the activation of
GSH synthesis. Conversely, CBS undergoes allosteric acti-
vation by SAMe, increasing its activity by 2.5-5 fold [10].
In summary, GSH synthesis is triggered by the oxidative
load but is effective only as long as SAMe is available,e one carbon cycle (upper part) provides activated methyl groups for
ivated by adenosylation to SAMe. Release of the carbon unit to any
ently remethylated (recycled) to methionine. Alternatively, Hcy may
th serine by the highly regulated cystathionine β-synthase (4), leading
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other Group B vitamins is in place.
Hcy is at the crossroads of two major metabolic path-
ways: GSH synthesis that regulates the redox balance
and trans-methylations that regulates gene expression
(imprinting) and cell growth. Hcy is also an inhibitor of
the methylation processes; it has an extremely negative
effect on spermatogenesis quality [11] and its concentra-
tion in the ejaculate is inversely correlated with fertility
outcome [12]. The same observations can be made for
oogenesis [13]. Failures in these pathways will decrease
endogenous glutathione and increase free homocysteine,
with knock-on effects on the related methylation pro-
cesses. Tailored nutritional support might be able to ac-
tivate such pathways, strengthening antioxidant defences
whilst supporting tissue growth and differentiation lead-
ing to an improved sperm maturation process.
A suitable oral nutritional support intended to feed and
activate the one carbon cycle and the transsulphuration
pathway should contain a full range of group B vitamins,
namely B2, B3, B6, B12, and B9 mandatory for recycling
homocysteine. N-Acetyl-Cysteine and/or L-cystine, the
only orally bioavailable precursors for the synthesis of
GSH, and Zinc are also important for homocysteine recyc-
ling. Zinc is as an essential co-factor for two key enzymes,
dihydrofolate reductase and methionine synthase, and
does not have any body reservoirs so that the circulating
level is largely dependent on daily intake.
Our aim was to test the efficacy of this combination of
substances in improving the fertility of ART-resistant male
partners who were selected on the basis of elevated DFI
and SDI. The combination (Condensyl™) also contained
small amounts of vitamin E, quercetin and betalains of
natural origin intended to provide some protection to the
cell membranes from excessive peroxidation.
Methods
Patients
The male partners of couples with at least 2 previous
ART failures and willing to undertake a further attempt
were screened for sperm chromatin integrity at 3 ART
clinics in France between August 2010 and March 2013.
Organic causes of male infertility were carefully ex-
cluded. DFI was measured by Terminal deoxynucleotidyl
transferase dUTP Nick End Labeling (TUNEL) and SDI
was measured by aniline blue staining at the reference
laboratories of the concerned clinics according to the
original methods [14,15]. TUNEL was selected because
it can be performed in situ and in case of low sperm
counts it has a good correspondence to flow cytometry
[16]. Chromatin decondensation was tested by aniline
blue staining because it has better specificity than the al-
ternative test, chromomycin A3, which overlaps to some
extent with TUNEL [17].Patients who had either a DFI or SDI exceeding the
20%, irrespective of their spermiogram, were offered nutri-
tional support in preparation of a new ART procedure. A
cut-off value for TUNEL-DFI higher than 20% was se-
lected based on our clinical experience and on published
evidence [18]. There is good consensus that a high DFI is
a marker for increased sperm DNA damage associated
with decreased embryo quality, decreased pregnancy rates
and higher rates of spontaneous miscarriage [19]. We also
selected patients based on a high aniline blue-SDI which,
in our clinical experience, is a strong predictor of repro-
ductive problems. Previous studies using a SDI cut-off
value of 10% [20,21] or 15% [22] showed only a discrete
predictive value so we used a higher inclusion value of
20%, aiming to be more selective.Intervention
This was an exploratory study in patients who had
already experienced repeated ART failures so excessive
study procedures and major changes in clinical manage-
ment were not ethically justified. The treatment was of-
fered to all the recruited patients without including a
control group. For the same reason the intervention was
limited to the offer of nutritional support to be taken ac-
cording to the product labeling, which is one or two tab-
let per day. Pre-existing dietary habits as well as other
possible environmental factors were not investigated but
patients were instructed note and report any major
changes occurring during the study period. Sperm sam-
pling and the evaluation of DFI and SDI was conducted
within the standard practice at the concerned centers and
did not require any procedural adjustment. Sperm sam-
pling and testing was performed at inclusion, as part of
the standard work-up, and at the time of the ART cycle.
Patients enjoying a spontaneous pregnancy were immedi-
ately asked for a sperm donation for research purposes.
The nutritional support consisted of a proprietary extract
of opuntia fig fruits (100 mg) delivering tailored amounts
of quercetin (0.05 mg) and betalain (0.001 mg) plus a mix
of Group B vitamins: B2 (1.4 mg), B3 (16 mg), B6 (1.4 mg),
B9 (400 μg), B12 (2.5 μg). The administered product also
contained zinc (12.5 mg) and small doses of N-acetyl-
cysteine (250 mg) and vitamin E (12 mg) (Condensyl™). All
the substances were dosed within the Recommended Daily
Allowance in the EU. The prescribed starting dose was 1
tablet per day and patients were informed that taking a lar-
ger dose of 2 tablets daily had the potential to produce
greater benefits but that it was not scientifically proven.
Targeted treatment duration was 4 months and was de-
pendent on the patient’s compliance and to the actual
planning of the following ART cycle. ART was performed
by IUI, IVF or ICSI balancing the clinical indication with
the couple’s willingness.
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This was an exploratory study, the group was not statis-
tically sized. In addition to basic descriptive statistics
(mean, range and standard deviation as appropriate),
statistical analysis was performed using IBM SPSS statis-
tics on a personal computer.
For continuous variables we used the Wilcoxon test or
the Mann–Whitney test. The Wilcoxon test was used to
compare two continuous variables in the same group of
patients. The Mann–Whitney test was used to compare
continuous variables in two independent groups. In both
cases, the null hypothesis was that the values are the
same and the alternative hypothesis was that the values
are different. A p value < 0.05 was assumed as statisti-
cally significant.
The independence of two categorical variables was
tested by the independence Chi2 test, also known as the
test of homogeneity. The null hypothesis was that the
two variables are independent, the alternative hypothesis
corresponds to the variables having an association or re-
lationship. A p value < 0.05 was assumed as statistically
significant.Results
A total of 84 patients fulfilled the entry criteria and gave
consent for the nutritional intervention. Their demo-
graphic characteristics are summarized in Table 1. In 28
cases (33%) there was an associated female factor: ovula-
tion disorders (n = 12), low anti-mullerian hormone (n =
9), polycystic ovaries with or without ovulation disorders
(n = 7). The majority of the patients were oligoasthenos-
permic (61%) or asthenospermic (17%) whereas about 1
in 4 (23%) was normospermic.
The average treatment duration was 130 days (range
59–365 days). Fifty-nine patients reported that they took
1 tablet per day, with 5 of them spontaneously increas-
ing it to 2 tablets per day during the treatment period.
The remaining 25 patients stated that they took 2 tablets
per day from the outset. The majority of the patients
were not able to report on the amount of missed doses
so that the actual compliance to the treatment could not
be assessed. None of the patients reported a majorTable 1 Demographic characteristics of patients and their
female partners
Patients Female partners
Mean age, years (range, SD) 37 (25–63, 5.5) 35 (25–44, 4.4)
Normospermic, n (%) 19 (23%)
Asthenospermic, n (%) 14 (17%)
Oligoasthenospermic, n (%) 51 (61%)
Female factor, n (%) 28 (33%)
Previous ART cycles (mean n, range) 2.4 (2–6)change in the dietary habits or environmental exposure
during the study period.
All patients were available for post-treatment DFI and
SDI evaluation, which occurred either at the time of the
new ART or immediately after the detection of a spon-
taneous pregnancy, as applicable. The average DFI sig-
nificantly decreased from 29.7% to 23.1% (p < 0.001) and
the average SDI significantly decreased from to 40.1% to
36.3% (p < 0.001). The responder rates (any index de-
crease) were 71.4% for DFI, 64.3% for SDI and 47.6% for
both DFI and SDI (Table 2). Male partners of women
with a female factor showed no improvement of either
their DFI (+0.8%) or SDI (+4.3%).
Treatment did not modify the total sperm count (p =
0.69), fast motility (p = 0.52) and normal morphology
(p = 0.1) rates. Normospermic patients had a lower aver-
age DFI at inclusion (p = 0.02). There were no dif-
ferences in normospermic patients vs astheno- and
oligoastheno-spermic patients in the percent decrease of
DFI (−3.1 vs −7.7%, p = 0.19) and SDI (−4.3 vs −3.6%, p =
0.6) or in the pregnancy rate (LBR 47.4 vs 28.6%, p = 0.41).
Pregnancy rates are summarized in Table 3. In all 40
clinical pregnancies were attained, 33 of them ending with
a live birth (1 medical abortion, 4 spontaneous losses, 1
lost at follow-up while ongoing, 1 still ongoing). Eighteen
couples (21%) experienced a spontaneous pregnancy dur-
ing the treatment, all of them ending with a live birth. The
remaining 66 couples underwent a new ART attempt
(4 IUI; 18 IVF; 44 ICSI), which resulted in 22 further clin-
ical pregnancies, resulting in 15 live births. The overall
clinical pregnancy rate (CPR) and live birth rate (LBR)
were 47.6% and 39.3% respectively. The 40 patients who
showed improvements in both indices obtained 28 preg-
nancies (CPR = 70%) and 23 live births (LBR = 57.5% - p <
0.000 vs patients not improving both indexes). Patients
improving SDI alone reported a higher CPR (p = 0.000)
and LBR (p = 0.000), those improving DFI alone reported
a higher CPR (p = 0.032). No pregnancies occurred in 10
patients failing to achieve any index improvement. Only 2
pregnancies (1 live birth) were recorded out of 28 couples
carrying a female factor compared with 38 pregnancies
(32 live births) out of 56 couples without an associated fe-
male problem (Table 4).
Duration of treatment had no effect on pregnancy rates:
patients treated for 3 months or less (n = 47) had a CPR of
48.9% and a LBR of 40.4% compared with 45.9% and
37.8% (ns) in those with a longer treatment term (n = 37).
It is to be noted that the study was not designed to detect
a treatment duration effect on pregnancy rates because, in
most instances, short duration of treatment was due to
the early occurrence of a spontaneous pregnancy (9/19
live births in the short treatment subgroup). In addition,
there was no significant dose effect of treatment on the
clinical response: patients taking 1 tablet per day (n = 54)




Pre Post % change Pre Post % change
All patients 84 (100) 29.7% 23.1% −6.6% (14,16)* 40.1% 36.3% −3.8% (13.87)*
DFI responders 60 (71%) 33.0% 20.0% −13.0% (10.66) 38.5% 34.6% −3.9% (13.64)
SDI responders 54 (64%) 28.5% 21.4% −7.0% (14.17) 42.0% 30.2% −11.8% (8.88)
DFI and SDI responders 40 (48%) 31.8% 18.8% −13.1% (10.74) 40.2% 28.9% −11.4% (8.40)
*p < 0.001, Wilcoxon test. Statistically significant differences in bold.
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with 50.0% and 33.3% (ns) in those taking more than 1
tablet per day (n = 30). However, these data are biased by
the lack of a reliable control on the actual administration
of the prescribed doses.
It was not possible to define DFI and/or SDI cut-off
values predictive of a successful pregnancy. However, pa-
tients achieving a pregnancy (n = 40), those experiencing a
spontaneous pregnancy (n = 18) and those achieving an
ART pregnancy (n = 22) all had a lower post-treatment
SDI due to a larger SDI decrease (p < 0.001). The sub-
group of patients achieving an ART pregnancy also had a
larger decrease of DFI which was of borderline signifi-
cance (p = 0.046). DFI and SDI response versus the occur-
rence of a clinical pregnancy is detailed in Table 5.
Discussion
The present study reports a CPR and a LBR of 47.6%
and 39.3% in ART-resistant couples carrying an idio-
pathic male factor, with or without an associated female
factor, following nutritional intervention to support the
one carbon cycle. It is noteworthy that more than half of
all live births (18 out of 33) were achieved spontan-
eously, i.e. during the run-up to a planned ART cycle.
The study was not controlled, therefore no conclu-
sions on the reported pregnancy rates can be drawn.
However, a recent follow-up study on another French
population [23] reported a cumulative chance of achiev-
ing a pregnancy for couples referring for a male factor of
60% after a 9-year follow-up (year 2000–2008). The birth
rate achieved by either ART or natural conception was




All patients 84 40 47.
Pts improving both DFI and SDI 40 28 70.
Pts improving SDI 54 35 64.
Pts improving DFI 60 33 55.
Pts not improving DFI nor SDI 10 0 0.0
Independence CHI2 test. Statistically significant differences in bold.rate at 2 years, which is far longer than the average
period of follow-up in our study, was 28%: 16% from
ART and 12% from natural pregnancy. Furthermore, the
reported follow-up study included patients at their first
referral and female factors had been excluded whereas
we included patients selected for proven resistance to
ART, irrespective of the presence of a female factor. A
comparison of the outcomes from the two studies sup-
ports the idea that fertility improvements might have
been gained with nutritional intervention.
The nutritional support resulted in a significant decrease
of both DFI and SDI, although the mean average magni-
tude of the decrease was not very high and a possible
spontaneous regression to the mean value might apply.
However this is unlikely as, in the absence of any thera-
peutic intervention, DFI and SDI are much more stable
over time than the classical semen parameters [24-26].
Moreover, in index response subgroups the magnitude of
the index decreases was large and the association with the
reproductive outcomes highly significant. In particular, the
SDI decrease exerted a very robust association with the
occurrence of pregnancies, both spontaneous and fol-
lowing an ART cycle, whereas the DFI decrease showed
a borderline correlation with the ART pregnancies.
In contrast with other male infertility studies, we en-
rolled our patients irrespective of the presence of a female
factor, which might better reflect the expected efficacy in
clinical practice. The CPR and LBR in the subgroup with
an associated female factor were only 4.2% and 2% com-
pared with 67.9% and 57.1% in couples without a known
female problem (Table 4). This may indicate that improve-
ments in sperm quality may be of little help as long as awith Condensyl™
regnancies Live births
te p n Rate p
6% 33 39.3%
0% 0.000 23 57.5% 0.001
8% 0.000 30 55.6% 0.000
0% 0.032 26 43.3% 0.23
% 0.001 0 0.0% 0.007
Table 4 DFI and SDI response and pregnancy rates according to the presence of any female factor
Groups n
DFI SDI Pregnancies
Pre Post % change P* Pre Post % change P* CPR (n) LBR (n)
Female factor YES 28 25.1% 25.9% 0.8% 0.145 41.6% 45.8% 4.3% 0.732 4.1% (2) 2.0% (1)
Female factor NO 56 32.1% 21.7% −10.4% 0.000 39.4% 31.6% −7.8% 0.000 67.9% (38) 57.1% (32)
P** 0.000 0.000
P*** 0.000 0.000
*Wilcoxon test; **Mann–Whitney test; ***Independence CHI2 test. Statistically significant differences in bold.
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these couples also failed completely to improve their frag-
mentation and decondensation indices which is, by defin-
ition, independent of the female factor and was, most
likely, due to very poor treatment compliance. For this
reason, the outcomes from this study should not be
grounds for not treating sperm defects if a female problem
also exists.
Besides confirming the role of the one carbon cycle in
male fertility and the potential benefit from nutritional
support, the present study is exploratory in nature and
design; it does not provide fundamental guidance re-
garding dose, length of treatment and the target values
of the various indices.
The amount of nutritional support taken by the pa-
tients was variable and we could not assess the actual
number of missed doses. The actual dose of treatment
taken is the main variable for any treatment that is left
in the patient’s control; in the absence of recurring trig-
ger symptoms may lead to the patients forgetting to take
their medication. Patient compliance motivation is also a
major variable - indirectly suggested by the lack of indi-
ces improvement in male partners of women with a fe-
male factor. In clinical practice we would expect to see
greater variability in compliance, which remains a main
constraint of any nutritional treatment.
The variable duration of intervention, ranging from 2–
12 months, was another weakness of the study. In mostTable 5 DFI and SDI response according to the occurrence of
Groups n (%)
DFI
Pre Post % cha
Any pregnancy
YES 40 (47.6) 29.4% 20.1% −9.3% (
NO 44 (52.4) 30.1% 25.9% −4.2% (
Spontaneous pregnancy
YES 18 (21.5) 23.2% 18.4% −4.8%
NO 66 (78.5) 31.5% 24.4% −7.2% (
ART pregnancy
YES 22 (33) 34.4% 21.4% −13.0%
NO 44 (67) 30.1% 25.9% −4.2% (
Mann–Whitney test. Statistically significant differences in bold.instances the short duration of treatment was due to the
occurrence of a spontaneous pregnancy whereas longer
durations were mainly associated with the patient’s will-
ingness and ability to accommodate the date of ART in
their lives. So there was little hope to discern any correl-
ation between treatment duration and reproductive out-
come. Nevertheless, in our clinical experience some
patients may require a longer treatment to achieve a re-
duction of SDI. In one Condensyl treated patient (not
included here) with a starting SDI of 42%, a first increase
up to 52% was observed. Then a progressive decline,
down to 13% occurred after 9 months of treatment, end-
ing with a spontaneous ongoing pregnancy (Tosti E,
2010 unpublished results).
The DFI cut-off value we used as the inclusion criter-
ion, >20%, confirmed to mark a worse prognosis. Indeed,
the 24 patients with a baseline DFI < 20% recorded a CPR
of 62.5% and a LBR of 54.2% compared with 41.7% and
33.3% in those with a higher baseline DFI, which did not
reach statistical significance possibly due to the small sam-
ple size. It is to be noted that the 15 patients achieving a
clinical pregnancy (13 live births) out of 24 with a baseline
DFI <20% had an elevated baseline SDI (45.5%) and
enjoyed a deep SDI decrease (−16.2%). Moreover, 9 out of
these clinical pregnancies and live births where achieved
spontaneously. Conversely, the 9 patients from this sub-
group not achieving a clinical pregnancy, who also had
a high baseline SDI (41.6%), failed at improving theira clinical pregnancy, mean values (standard deviation)
SDI
nge p Pre Post % change p
13.61) 0.168 40.6% 29.3% −11.3% (12.81) 0.000
14.38) 39.6% 42.6% 3.0% (11.10)
(9.38) 0.571 44.8% 29.8% −15.0% (11.11) 0.000
15.23) 38.8% 38.0% −0.7% (13.00)
(15.52) 0.046 37.2% 29.0% −8.2% (13.54) 0.001
14.38) 39.6% 42.6% 3.0% (11.10)
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tive outcome. In addition, 8 out of these 9 patients had an
associated female factor, i.e. they are among those strongly
suspected of poor compliance. In spite of the very small
sample, these data taken together seem to identify a sub-
group of infertile patients, those referring with low DFI
and high SDI, who have a very high chance of benefiting
from the tested nutritional support and this group should
be tested in larger prospective trials. Only 4 patients (3 live
births) had a baseline SDI below the 20% inclusion cut-off
value, thus the sample is too small to allow similar
speculation.
The target levels of DFI and SDI marking a positive
outcome also remain unaddressed as we did not identify
cut-off values. This is likely due to the small sample size,
but other mechanisms might apply. Eight out of 18
spontaneous pregnancies recorded in this study occurred
in patients whose final SDI was still above the critical
level of 30% but all of them had enjoyed a relative de-
crease greater than 15%. The same trend applied, with
less evidence, to the changes in DFI.
In any case it is clear that, in our model, SDI exerted a
far greater effect on pregnancies than DFI (Table 5). In-
deed, the DNA damage related to the DFI increase can be
repaired within the zygote whose DNA repair activity is,
by definition, of maternal origin [27]. Thus the final effect
of sperm fragmentation level depends on the variable
DNA repair ability of the fertilized oocyte, i.e. the oocyte
quality; which makes it a less direct measurement of the
male partner contribution to a couple’s infertility. Con-
versely, damage to sperm chromatin organisation detected
by sperm nuclear decondensation has little chance of be-
ing repaired by the oocyte/zygote and directly reflects the
male contribution to infertility.
In summary, DFI and SDI are good indices of defective
sperm quality but do not appear to be the best markers
for the response to treatment so more specific tests are
required. In our study chromatin decondensation index,
which can be assessed either by aniline blue staining or
by SCSA (HDS index), had the strongest correlation
with outcome. To date it has been largely neglected.
The present study reports positive effects of dietary inter-
vention on sperm damage indices and, possibly, on male
fertility competence based upon a series of studies [3,5] on
the same topic. In spite of the heterogeneity of design, as-
sessment criteria and in the type and combinations of sub-
stances administered, all of these studies share a common
aim: to readdress the oxidative imbalance. All point to-
wards some positive effects; little doubt remains about the
concept that sperm oxidative damage is a relevant clinical
target and that it can be positively influenced by tailored
nutritional supplementation. Nevertheless, the best pos-
sible interventional approach remains open to question
and the present study may help elucidate this discussion.The combination of substances administered to our pa-
tients had the potential to affect the sperm maturation
process. Group B vitamins, which are cofactors for certain
key metabolic enzymes, are available to the sperm but the
amount is dependent on daily intake. The same applies to
zinc. Moreover, zinc and vitamin B9 (folic acid), orally ad-
ministered alone or in combination, have already been
shown to positively influence sperm protamine content
and acrosomal integrity [28]. N-acetyl-cysteine is soluble
so it is easily absorbed and readily transformed into cyst-
eine within the cell by the ubiquitous deacetylation reac-
tion. Accordingly, oral administration of N-acetyl-cysteine
was shown to improve semen parameters and the oxi-
dative/antioxidant status in patients with male infertility
[29]. Vitamin E is also readily available intracellularly and
improved sperm motility as well as fertilising capacity
when orally co-administered with zinc at a dose (20 mg
per day) similar to that used in our study [30]. Finally, the
importance of the availability of these substances from the
diet and their effect on sperm function is confirmed by
epidemiological findings. Men with the highest intake of
vitamin E, folate, and zinc show less sperm DNA damage
and older men with the highest intake of these micronutri-
ents showed levels of sperm damage that were similar to
those of younger men [31]. The combination of nutrients
administered to our patients included substances which
are either already widely used for nutritional support to
spermatogenesis or had already been shown either alone or
in combination to positively influence the redox balance.
From a chemical point of view the term antioxidant re-
fers to compounds that prevent or delay the oxidation of
other compounds; these include enzymatic (e.g. super-
oxide dismutase), non-enzymatic (e.g. vitamin C) and in-
direct antioxidants (e.g. chelating agents) [32]. The
substances administered to our patients all belong to the
class of indirect or very indirect antioxidants. The group B
vitamins used are unable to directly reduce another sub-
stance; they only act as methyl donors or as co-enzymes
for the one carbon cycle, i.e. they sustain transmethyla-
tions. In turn, full efficiency of Hcy remethylation provides
amounts of SAMe that are essential for the activation of
GSH synthesis, thereby raising antioxidant defence cap-
acity. The same applies to zinc. Although formerly consid-
ered an antioxidant, N-acetyl-cysteine is also incapable of
reducing other substances. It is, however, proven to act as
a precursor for GSH synthesis and no further reducing ef-
fects can be demonstrated once GSH synthesis is saturated
[33]. Betalains, which are provided in small amounts by
our opuntia extract, have been demonstrated to be bio-
available and to selectively bind to lipids to prevent their
oxidation, so reducing the burden of the lipoperoxidation
cascade [34]. Quercetin (also from the opuntia extract)
displays lipid membrane tropism whereby it inhibits the
peroxidative cascade by chelating pro-oxidant metals [35].
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burden of endogenous oxidative load from lipid peroxi-
dation but do not directly induce a reductive environ-
ment. Finally, vitamin E is actively antioxidant at doses
of 300 mg per day [36]: at the doses used in our study
(12 mg per tablet) it can only exert mild protection on
lipid peroxidation and cannot induce a reducing intra-
cellular environment. Combined, these substances provide
the necessary tools to push intracellular homeostasis to-
wards fuller antioxidant capacity (GSH) while simultan-
eously supporting cellular growth and differentiation (one
carbon cycle). This contrasts markedly with the artificial
reducing environment produced by loading the system
with direct antioxidants. A distinct added advantage of
our approach is the minimization of the risk of induced
“reductive” stress; precision of dosing is less critical as a
result.
Our treatment (Condensyl™), is devoid of any direct anti-
oxidants, apart from small amounts of vitamin E, and our
results demonstrated a significant decrease of DFI, which
is well known to be dependent on oxidative processes.
These outcomes strongly support a primary role of the
one-carbon cycle, in addition to its clear involvement in
the transmethylations in redox regulation within the
sperm cell. On the other hand, we could not investigate
the effect of treatment on the global oxy-redox status of
the patients and on the amount of oxidative DNA damage
(e.g. 8-hydroxy-2′-deoxyguanosine levels), so a direct dem-
onstration is still lacking. However, for the first time to the
authors’ knowledge, and in direct contrast to the results
obtained with strong oral antioxidants [8], the decrease of
DFI paralleled a significant decrease of SDI, indicating that
no reductive stress had occurred.
Conclusions
The high degree of correlation of fertility improvement
with the decrease of the decondensation index further
supports the importance of the chromatin structure on
the reproductive outcomes and its susceptibility to envir-
onmental factors, pollution and pro-oxidants on the one
hand and dietary manipulation on the other. Sperm
DNA damage indexes, DFI and SDI, confirm to mark a
poor prognosis with SDI decrease exerting a robust rela-
tion with a positive outcome. Group B vitamins and
their co-factors (Condensyl™) appear to be safe and ef-
fective and might improve the outcomes in both natural
and assisted reproduction. Finally, a deeper investigation
of the complex metabolic framework of human gametes
has the potential to produce break-through understand-
ing in the physiology of human reproduction and in its
pathological conditions too.
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